Reliability of sample collection and laboratory testing for HPV Detection in Men

Journal of Virological Methods

Volumn 149, Issue 1, 2008, Pages 136-143

  Flores, Roberto ^a   Abalos, Andrew T ^b   Nielson, Carrie M ^c   Abrahamsen, Martha ^a   Harris, Robin B ^b   Giuliano, Anna R ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Collection; HPV; Papillomavirus; Reliability; Reproducibility; Specimen

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; GENOTYPE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MALE GENITAL SYSTEM; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELIABILITY; SAMPLING; SKIN TEST; VERRUCA VULGARIS; VIRUS DETECTION; WART VIRUS;

ADOLESCENT; ADULT; DNA, VIRAL; GENOTYPE; HUMANS; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SPECIMEN HANDLING;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

EID: 40849139065     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2007.12.010     Document Type: Article

References (35)

1. Agarwal S.S., Sehgal A., Sardana S., Kumar A., and Luthra U.K. Role of male behavior in cervical carcinogenesis among women with one lifetime sexual partner. Cancer 72 (1993) 1666-1669
2. Baldwin S.B., Wallace D.R., Papenfuss M.R., Abrahamsen M., Vaught L.C., Kornegay J.R., Hallum J.A., Redmond S.A., and Giuliano A.R. Human papillomavirus infection in men attending a sexually transmitted disease clinic. J. Infect. Dis. 187 (2003) 1064-1070
3. Bosch F.X., Castellsague X., Munoz N., de Sanjose S., Ghaffari A.M., Gonzalez L.C., Gili M., Izarzugaza I., Viladiu P., Navarro C., Vergara A., Ascunce N., Guerrero E., and Shah K.V. Male sexual behavior and human papillomavirus DNA: key risk factors for cervical cancer in Spain. J. Natl. Cancer Inst. 88 (1996) 1060-1067
4. Canadas M.P., Bosch F.X., Junquera M.L., Ejarque M., Font R., Ordonez E., and de Sanjose S. Concordance of prevalence of human papillomavirus DNA in anogenital and oral infections in a high-risk population. J. Clin. Microbiol. 42 (2004) 1330-1332
5. Castellsague X., Ghaffari A., Daniel R.W., Bosch F.X., Munoz N., and Shah K.V. Prevalence of penile human papillomavirus DNA in husbands of women with and without cervical neoplasia: a study in Spain and Colombia. J. Infect. Dis. 176 (1997) 353-361
6. Coutlee F., Rouleau D., Petignat P., Ghattas G., Kornegay J.R., Schlag P., Boyle S., Hankins C., Vezina S., Cote P., Macleod J., Voyer H., Forest P., Walmsley S., and Franco E. Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the linear array HPV genotyping test. J. Clin. Microbiol. 44 (2006) 1998-2006
7. Daniel R.W., Ahdieh L., Hayden D., Cu-Uvin S., and Shah K.V. Intra-laboratory reproducibility of human papillomavirus identification in cervical specimens by a polymerase chain reaction-based assay. J. Clin. Virol. 19 (2000) 187-193
8. Dunne E.F., Nielson C.M., Stone K.M., Markowitz L.E., and Giuliano A.R. Prevalence of HPV infection among men: a systematic review of the literature. J. Infect. Dis. 194 (2006) 1044-1057
9. Fife K.H., Coplan P.M., Jansen K.U., DiCello A.C., Brown D.R., Rojas C., and Su L. Poor sensitivity of polymerase chain reaction assays of genital skin swabs and urine to detect HPV 6 and 11 DNA in men. Sex. Transm. Dis. 30 (2003) 246-248
10. Flores R., Papenfuss M., McAnany S., Kornegay J., Gravitt P., and Giuliano A. Inter-laboratory assessment of the linear array genotyping test for the study of HPV infection in men. Proceedings of the 23rd International Papillomavirus Conference and Clinical Workshop. Prague, Czech Republic (2006)
11. Giuliano A.R., Nielson C.M., Flores R., Dunne E.F., Abrahamsen M., Papenfuss M.R., Markowitz L.E., Smith D., and Harris R.B. The optimal anatomic sites for sampling heterosexual men for human papillomavirus (HPV) detection: the HPV detection in men study. J. Infect. Dis. 196 (2007) 1146-1152
12. Gravitt P.E., Peyton C.L., Alessi T.Q., Wheeler C.M., Coutlee F., Hildesheim A., Schiffman M.H., Scott D.R., and Apple R.J. Improved amplification of genital human papillomaviruses. J. Clin. Microbiol. 38 (2000) 357-361
13. Gravitt P.E., Peyton C.L., Apple R.J., and Wheeler C.M. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J. Clin. Microbiol. 36 (1998) 3020-3027
14. Hernadi Z., Szoke K., Sapy T., Krasznai Z.T., Soos G., Veress G., Gergely L., and Konya J. Role of human papillomavirus (HPV) testing in the follow-up of patients after treatment for cervical precancerous lesions. Eur. J. Obstet. Gynecol. Reprod. Biol. 118 (2005) 229-234
15. Hernandez B.Y., McDuffie K., Goodman M.T., Wilkens L.R., Thompson P., Zhu X., Wong W., and Ning L. Comparison of physician- and self-collected genital specimens for detection of human papillomavirus in men. J. Clin. Microbiol. 44 (2006) 513-517
16. Khan M.J., Castle P.E., Lorincz A.T., Wacholder S., Sherman M., Scott D.R., Rush B.B., Glass A.G., and Schiffman M. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J. Natl. Cancer Inst. 97 (2005) 1072-1079
17. Koliopoulos G., Arbyn M., Martin-Hirsch P., Kyrgiou M., Prendiville W., and Paraskevaidis E. Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies. Gynecol. Oncol. 104 (2007) 232-246
18. Kornegay J.R., Roger M., Davies P.O., Shepard A.P., Guerrero N.A., Lloveras B., Evans D., and Coutlee F. International proficiency study of a consensus L1 PCR assay for the detection and typing of human papillomavirus DNA: evaluation of accuracy and intralaboratory and interlaboratory agreement. J. Clin. Microbiol. 41 (2003) 1080-1086
19. Landis J.R., and Koch G.G. The measurement of observer agreement for categorical data. Biometrics 33 (1977) 159-174
20. Levine R.U., Crum C.P., Herman E., Silvers D., Ferenczy A., and Richart R.M. Cervical papillomavirus infection and intraepithelial neoplasia: a study of male sexual partners. Obstet. Gynecol. 64 (1984) 16-20
21. Nielson C.M., Flores R., Harris R.B., Abrahamsen M., Papenfuss M.R., Dunne E.F., Markowitz L.E., and Giuliano A.R. Human papillomavirus prevalence and type distribution in male anogenital sites and semen. Cancer Epidemiol. Biomarkers Prev. 16 (2007) 1107-1114
22. Revzina N.V., and Diclemente R.J. Prevalence and incidence of human papillomavirus infection in women in the USA: a systematic review. Int. J. STD AIDS 16 (2005) 528-537
23. Ronco G., Giorgi-Rossi P., Carozzi F., Dalla Palma P., Del Mistro A., De Marco L., De Lillo M., Naldoni C., Pierotti P., Rizzolo R., Segnan N., Schincaglia P., Zorzi M., Confortini M., and Cuzick J. Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial. Lancet Oncol. 7 (2006) 547-555
24. Sanclemente G., and Gill D.K. Human papillomavirus molecular biology and pathogenesis. J. Eur. Acad. Dermatol. Venereol. 16 (2002) 231-240
25. Schiffman M., Hildesheim A., Herrero R., and Bratti C. Human papillomavirus testing as a screening tool for cervical cancer. JAMA 283 (2000) 2525-2526
26. Schiffman M.H., Kiviat N.B., Burk R.D., Shah K.V., Daniel R.W., Lewis R., Kuypers J., Manos M.M., Scott D.R., Sherman M.E., et al. Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture. J. Clin. Microbiol. 33 (1995) 545-550
27. Schlecht N.F., Kulaga S., Robitaille J., Ferreira S., Santos M., Miyamura R.A., Duarte-Franco E., Rohan T.E., Ferenczy A., Villa L.L., and Franco E.L. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 286 (2001) 3106-3114
28. Solomon D., Schiffman M., and Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J. Natl. Cancer Inst. 93 (2001) 293-299
29. Thomas D.B., Ray R.M., Kuypers J., Kiviat N., Koetsawang A., Ashley R.L., Qin Q., and Koetsawang S. Human papillomaviruses and cervical cancer in Bangkok. III. The role of husbands and commercial sex workers. Am. J. Epidemiol. 153 (2001) 740-748
30. van Hamont D., van Ham M.A., Bakkers J.M., Massuger L.F., and Melchers W.J. Evaluation of the SPF10-INNO LiPA human papillomavirus (HPV) genotyping test and the roche linear array HPV genotyping test. J. Clin. Microbiol. 44 (2006) 3122-3129
31. Villa L.L., Costa R.L., Petta C.A., Andrade R.P., Paavonen J., Iversen O.E., Olsson S.E., Hoye J., Steinwall M., Riis-Johannessen G., Andersson-Ellstrom A., Elfgren K., Krogh G., Lehtinen M., Malm C., Tamms G.M., Giacoletti K., Lupinacci L., Railkar R., Taddeo F.J., Bryan J., Esser M.T., Sings H.L., Saah A.J., and Barr E. High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. Br. J. Cancer 95 (2006) 1459-1466
32. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., Snijders P.J., Peto J., Meijer C.J., and Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189 (1999) 12-19
33. Weaver B.A., Feng Q., Holmes K.K., Kiviat N., Lee S.K., Meyer C., Stern M., and Koutsky L.A. Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men. J. Infect. Dis. 189 (2004) 677-685
34. Weinstock H., Berman S., and Cates Jr. W. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod. Health 36 (2004) 6-10
35. zur Hausen H. Papillomavirus infections-a major cause of human cancers. Biochim. Biophys. Acta 1288 (1996) F55-F78